<SEC-DOCUMENT>0001437749-24-038601.txt : 20241231
<SEC-HEADER>0001437749-24-038601.hdr.sgml : 20241231
<ACCEPTANCE-DATETIME>20241231160818
ACCESSION NUMBER:		0001437749-24-038601
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20241224
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241231
DATE AS OF CHANGE:		20241231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PARKERVISION INC
		CENTRAL INDEX KEY:			0000914139
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				592971472
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22904
		FILM NUMBER:		241593085

	BUSINESS ADDRESS:	
		STREET 1:		4446 - 1A HENDRICKS AVENUE
		STREET 2:		SUITE 354
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32207
		BUSINESS PHONE:		9047326100

	MAIL ADDRESS:	
		STREET 1:		4446 - 1A HENDRICKS AVENUE
		STREET 2:		SUITE 354
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32207
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>prkr20241230_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:prkr="http://www.prkr.com/20241224"><head>
	<title>prkr20241230_8k.htm</title>

<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-right: 10px; margin-left: 10px; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag" id="ixv-287">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey" id="ixv-288">0000914139</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="prkr-20241224.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000914139</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-12-24</xbrli:startDate>
<xbrli:endDate>2024-12-24</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>
<!-- Created by RDG Portal -->
<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>UNITED STATES</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>______________</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>FORM <ix:nonNumeric contextRef="d20248K" name="dei:DocumentType" id="ixv-17"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>CURRENT REPORT</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-27"><span style="text-decoration: underline;">December 24, 2024</span></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName" id="ixv-31"><span style="text-decoration: underline;">PARKERVISION, INC.</span></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">(Exact Name of Registrant as Specified in Charter)</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 582px; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: 592px; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: 569px; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 582px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-43"><span style="text-decoration: underline;">Florida</span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 592px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber" id="ixv-47"><span style="text-decoration: underline;">000-22904</span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: 569px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber" id="ixv-51"><span style="text-decoration: underline;">59-2971472</span></ix:nonNumeric></div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 582px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">(State or Other Jurisdiction of Incorporation)</div>
			</td>
			<td style="vertical-align: top; width: 592px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align: top; width: 569px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">(IRS Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 1216px; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: 528px; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 1216px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1" id="ixv-69"><span style="text-decoration: underline;">4446-1A Hendricks Avenue</span><span style="text-decoration: underline;"> <span style="text-decoration: underline;">Suite 354</span></span></ix:nonNumeric><span style="text-decoration: underline;">, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown" id="ixv-74"><span style="text-decoration: underline;"><span style="text-decoration: underline;">Jacksonville</span></span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-77"><span style="text-decoration: underline;"><span style="text-decoration: underline;">Florida</span></span></ix:nonNumeric></span></div>
			</td>
			<td style="vertical-align: top; width: 528px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode" id="ixv-82"><span style="text-decoration: underline;">32207</span></ix:nonNumeric></div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 1216px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">(Address of Principal Executive Offices)</div>
			</td>
			<td style="vertical-align: top; width: 528px; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">(Zip Code)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><span style="text-decoration: underline;">(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode" id="ixv-92"><span style="text-decoration: underline;"><span style="text-decoration: underline;">904</span></span></ix:nonNumeric>) <ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber" id="ixv-95"><span style="text-decoration: underline;"><span style="text-decoration: underline;">732-6100</span></span></ix:nonNumeric></span></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><span style="text-decoration: underline;">N/A</span></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2. below):</div>

<div style="margin: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-298">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-299">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-300">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-301">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: center;"><span style="text-decoration: underline;">Title of Each Class</span></div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><span style="text-decoration: underline;">Trading Symbol</span></div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><span style="text-decoration: underline;">Name of Each Exchange on Which Registered</span></div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: center;">None</div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Emerging growth company&#160;&#160;&#160;<ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-302">&#9744;</ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Item 1.01.</b>&#160;&#160;&#160;&#160;&#160;&#160;<b> Entry into a Material Definitive Agreement.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">On December 24, 2024 ParkerVision, Inc. (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;) entered into securities purchase agreements (the &#8220;<span style="text-decoration: underline;">Purchase Agreement</span>&#8221;) with accredited investors which provides for the sale of&#160;an aggregate of 5,958,402 unregistered shares of ParkerVision common stock, $0.01 par value (&#8220;Shares&#8221;) and 1,000,0000 warrants ("Warrants"), at a price of $0.50 per share.&#160; On December 30, 2024, the Company entered into a Purchase Agreement with an accredited investor which provides for the sale of 4,041,598 Shares and 1,000,000 Warrants, also at a price of $0.50 per share.&#160; The accredited investors are identified on Exhibit 10.4 hereof (the "Investors").&#160; The Warrants are exercisable for a period of five years at an exercise price of $0.50 per share.&#160; The Purchase Agreement contains customary representations and warranties of the Investors. &#160;The aggregate proceeds from the sale of Shares of $5,000,000 will be used to fund the Company's operations, including litigation-related expenses.&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">The Company also entered into&#160;registration rights agreements (the &#8220;<span style="text-decoration: underline;">Registration Rights Agreement</span>&#8221;) with the Investors pursuant to which the Company will register the shares of Common Stock and the shares underlying the Warrants.&#160; The Company has committed to file the registration statement no later than April 15, 2025, and to cause the registration statement to become effective by May 20, 2025, or, in the event of a full review by the Securities and Exchange Commission, no later than July 14, 2025.&#160; The Registration Rights Agreement provides for liquidated damages upon the occurrence of certain events including failure by the Company to file the registration statement or cause it to become effective by the deadlines set forth above.&#160; The amount of the liquidated damages is 1.0% of the aggregate subscription amount paid by the Investors upon the occurrence of the event, and monthly thereafter, up to a maximum of 6%, or $300,000.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">The Shares and Warrants were offered and sold solely to accredited investors on a private placement basis under Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">The foregoing summaries of the Purchase Agreement, the Registration Rights Agreement, and the Warrant are qualified in their entirety by reference to the full text of the agreements, which are attached as part of Exhibits 10.1, 10.2, and 10.3 hereto and are incorporated herein by reference.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 71pt; text-indent: -72pt;"><b>Item 3.02.</b>&#160;&#160;&#160;&#160;&#160;&#160;<b> Unregistered Sales of Equity Securities.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -1pt;">The disclosures included in Item 1.01 are incorporated herein by reference to the extent required.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Item 9.01 </b>&#8211;<b> Financial Statements and Exhibits.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">(d)&#160;Exhibits</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-size: 11pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 13.3%; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Exhibit</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 92.8%; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-size: 11pt;">
			<td style="vertical-align: top; width: 13.3%; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">10.1</div>
			</td>
			<td style="vertical-align: top; width: 92.8%; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><a href="ex_761249.htm" style="-sec-extract:exhibit;">Form of Securities Purchase Agreement</a></div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-size: 11pt;">
			<td style="vertical-align: top; width: 13.3%; font-size: 11pt;">10.2</td>
			<td style="vertical-align: top; width: 92.8%; font-size: 11pt;"><a href="ex_761250.htm" style="-sec-extract:exhibit;">Form of Registration Rights Agreement</a></td>
		</tr>
		<tr style="font-size: 11pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 13.3%; font-size: 11pt;">10.3</td>
			<td style="vertical-align: top; width: 92.8%; font-size: 11pt;"><a href="ex_761251.htm" style="-sec-extract:exhibit;">Form of Warrant</a></td>
		</tr>
		<tr style="font-size: 11pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 13.3%; font-size: 11pt;">10.4</td>
			<td style="vertical-align: top; width: 92.8%; font-size: 11pt;"><a href="ex_761252.htm" style="-sec-extract:exhibit;">Schedule of Investors</a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 13.3%; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: 92.8%; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 13.3%; font-size: 11pt;">104</td>
			<td style="vertical-align: top; width: 92.8%; font-size: 11pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 8pt;"><b>SIGNATURE</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Dated: December 31, 2024</div>
			</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">PARKERVISION,&#160;INC.</div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">By&#160;/s/&#160;Cynthia French</div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Cynthia&#160;French</div>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-size: 11pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Chief&#160;Financial&#160;Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_761249.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_761249.htm</title>
	<!-- Generated by ThunderDome Portal - 12/30/2024 7:09:18 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 10.1</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES PURCHASE AGREEMENT</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">This Securities Purchase Agreement (this &#8220;<u>Agreement</u>&#8221;) is dated as of December [&#9679;], 2024 between ParkerVision, Inc., a Florida corporation (the &#8220;<u>Company</u>&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;<u>Purchaser</u>&#8221; and collectively, the &#8220;<u>Purchasers</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>ARTICLE I.</b><br>
<b>&nbsp;&nbsp;&nbsp;&nbsp;DEFINITIONS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">1.1<u>&nbsp;&nbsp;&nbsp;&nbsp;Definitions</u>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Action</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(i).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Board of Directors</u>&#8221; means the board of directors of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">&#8220;<u>Business Day</u>&#8221; means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Closing</u>&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Closing Date</u>&#8221; means the Trading Day when all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Securities have been satisfied or waived.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Commission</u>&#8221; means the United States Securities and Exchange Commission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Common Stock</u>&#8221; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such securities may hereafter be reclassified or changed into.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Common Stock Equivalents</u>&#8221; means any securities of the Company or any subsidiary which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Company Counsel</u>&#8221; means Graubard Miller, with offices located at The Chrysler Building, 405 Lexington Avenue, New York, New York 10174.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Disclosure Schedules</u>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith and attached to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Evaluation Date</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(r).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">&#8220;<u>GAAP</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(g).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">&#8220;<u>Intellectual Property</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(o).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Legend Removal Date</u>&#8221; shall have the meaning ascribed to such term in Section 4.1(c).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Lien</u>&#8221; means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Material Adverse Effect</u>&#8221; shall have the meaning assigned to such term in Section 3.1(a).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Material Permits</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(m).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Per Share Purchase Price</u>&#8221; equals $0.50, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Person</u>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Proceeding</u>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Public Information Failure</u>&#8221; shall have the meaning ascribed to such term in Section 4.2(b).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Public Information Failure Payments</u>&#8221; shall have the meaning ascribed to such term in Section 4.2(b).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 72pt;">&#8220;<u>Purchaser Party</u>&#8221; shall have the meaning ascribed to such term in Section 4.8.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Registration Rights Agreement</u>&#8221; means the Registration Rights Agreement, dated the date hereof, among the Company and the Purchasers, in the form of <u>Exhibit A</u> attached hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Registration Statement</u>&#8221; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the Purchasers of the Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Required Approvals</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(d).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;SEC Reports</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(g).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Securities</u>&#8221; means the Shares, the Warrants and the Warrant Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Shares</u>&#8221; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Short Sales</u>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Subscription Amount</u>&#8221; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately available funds.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Trading Market</u>&#8221; means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the Over-the-Counter Bulletin Board (the OTCQB, the OTCQX or the &#8220;Pink Sheets&#8221; published by The OTC Markets Group, Inc. or a similar organization or agency succeeding to its functions or reporting prices), or any successors to any of the foregoing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Transaction Documents</u>&#8221; means this Agreement, the Registration Rights Agreement, the Warrants, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Transfer Agent</u>&#8221; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 55 Challenger Road, Floor 2, Ridgefield Park, NJ 07660, and any successor transfer agent of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Warrants</u>&#8221; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at Closing in accordance with Section 2.2(a) hereof, which Warrants shall be exercisable from the Closing Date and have a term of exercise equal to five (5) years, in the form of <u>Exhibit B</u> attached hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Warrant Shares</u>&#8221; means the shares of Common Stock issuable upon exercise of the Warrants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>ARTICLE II.</b><br>
<b>&nbsp;&nbsp;&nbsp;&nbsp;PURCHASE AND SALE</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">2.1<u>&nbsp;&nbsp;&nbsp;&nbsp;Closing</u>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $5,000,000<b> </b>of<b> </b>Shares and Warrants. Each Purchaser shall deliver to the Company via wire transfer of immediately available funds equal to its Subscription Amount and the Company shall deliver to each Purchaser its respective Shares and a Warrant, as determined pursuant to Section 2.2(a)(iii), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">2.2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Deliveries</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;On the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;this Agreement duly executed by the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the number of shares of Common Stock specified below such Purchaser&#8217;s name on the signature page of this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;a Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock specified below such Purchaser&#8217;s name on the signature page of this Agreement, with an exercise price equal to $0.50 per share, subject to adjustment as described therein (such Warrant certificate may be delivered within two Trading Days of the Closing Date); and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Registration Rights Agreement duly executed by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;On the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;this Agreement duly executed by such Purchaser;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;an Accredited Investor Questionnaire executed by such Purchaser;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;such Purchaser&#8217;s Subscription Amount by wire transfer to the account as specified in writing by the Company; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Registration Rights Agreement duly executed by such Purchaser.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 14pt; text-indent: 36pt;">2.3<u>&nbsp;&nbsp;&nbsp;&nbsp; Closing Conditions</u>.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met (provided, however, that any Purchaser, as to itself only and without any effect whatsoever on the rights and obligations between the Company and the other Purchasers, may waive any one or more than one of such Closing conditions by written notice to the Company):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>ARTICLE III.</b><br>
<b>&nbsp;&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">3.1<u>&nbsp;&nbsp;&nbsp;&nbsp;Representations and Warranties of the Company</u>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser as of the date hereof and as of the Closing Date (unless as of a specific date therein):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)<u>&nbsp;&nbsp;&nbsp;&nbsp;Subsidiaries; Organization and Qualification</u>. All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. The Company and each of its subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any subsidiary is in violation or default of any of the provisions of its articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and its subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<u>Material Adverse Effect</u>&#8221;), and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)<u>&nbsp;&nbsp;&nbsp;&nbsp;Authorization; Enforcement</u>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(c)<u>&nbsp;&nbsp;&nbsp;&nbsp;No Conflicts</u>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents by the Company, the issuance and sale of the Securities and the consummation by the Company of the other transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&#8217;s articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(d)<u>&nbsp;&nbsp;&nbsp;&nbsp;Filings, Consents and Approvals</u>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than (i) such filings, if any, as are required to be made under applicable Federal and state securities laws, including the filings required pursuant to Section 4.4, the filing with the Commission of a Registration Statement and the filing with the Commission of a Form D, (ii) such notices or applications, if any, as are required to be given or made to the Trading Market for the issuance and sale of the Securities and the listing or quotation of the Shares and the Warrant Shares for trading thereon, if any and (iii) such filings as are required to be made under applicable state securities laws (the &#8220;<u>Required Approvals</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(e)<u>&nbsp;&nbsp;&nbsp;&nbsp;Issuance of the Securities</u>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(f)<u>&nbsp;&nbsp;&nbsp;&nbsp;Capitalization</u>. <u>Capitalization</u>. The capitalization of the Company as of the date hereof is as set forth on <u>Schedule 3.1(f</u>) of the Disclosure Schedules. Except as set forth in the SEC Reports or <u>Schedule 3.1(f)</u>, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options and the vesting of restricted stock units under the Company&#8217;s equity incentive plans and pursuant to the conversion or exercise or exchange of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth in the SEC Reports or <u>Schedule 3.1(f)</u> and except for outstanding awards under the Company&#8217;s equity incentive plans, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(g)<u>&nbsp;&nbsp;&nbsp;&nbsp;SEC Reports; Financial Statements</u>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials filed prior to the date hereof, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;<u>SEC Reports</u>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<u>GAAP</u>&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(h)<u>&nbsp;&nbsp;&nbsp;&nbsp;Material Changes; Undisclosed Events, Liabilities or Developments</u>. Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in the SEC Reports and schedule 3.1 (h), (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, except in connection with the payment of the exercise price of, or withholding taxes for, awards under the Company&#8217;s equity incentive plans, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to the Company&#8217;s existing equity incentive plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists with respect to the Company or its business, properties, operations, financial condition or prospects that would be required to be publicly disclosed by the Company under applicable securities laws at the time this representation is made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made, except as set forth in schedule 3.1(h).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(i)<u>&nbsp;&nbsp;&nbsp;&nbsp;Litigation</u>. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, Proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company or any of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<u>Action</u>&#8221;) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. To the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the Exchange Act or the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(j)<u>&nbsp;&nbsp;&nbsp;&nbsp;Labor Relations</u>. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#8217;s employees is a member of a union that relates to such employee&#8217;s relationship with the Company, and the Company is not a party to a collective bargaining agreement, and the Company believes that its relationship with its employees is good. No executive officer of the Company, to the knowledge of the Company, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each such executive officer does not subject the Company to any liability with respect to any of the foregoing matters. The Company is in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(k)<u>&nbsp;&nbsp;&nbsp;&nbsp;Compliance</u>. Except as set forth in the SEC Reports, the Company (i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company under), nor has the Company received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is not in violation of any judgment, decree or order of any court, arbitrator or other governmental authority, or (iii) is not and has not been in violation of any statute, rule or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws applicable to its business and all such laws that affect the environment, except in each case as could not reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(l)<u>&nbsp;&nbsp;&nbsp;&nbsp;Environmental Laws</u>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &#8220;<u>Hazardous Materials</u>&#8221;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#8220;<u>Environmental Laws</u>&#8221;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(m)<u>&nbsp;&nbsp;&nbsp;&nbsp;Regulatory Permits</u>. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct its business as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;<u>Material Permits</u>&#8221;), and the Company has not received any notice of proceedings relating to the revocation or modification of any Material Permit.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(n)<u>&nbsp;&nbsp;&nbsp;&nbsp;Title to Assets</u>. The Company has good and marketable title in fee simple to all real property owned by it that is material to the business of the Company and good and marketable title in all personal property owned by it that is material to the business of the Company, in each case free and clear of all Liens, except for Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company are held by it under valid, subsisting and enforceable leases with which the Company is in compliance.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(o)<u>&nbsp;&nbsp;&nbsp;&nbsp;Intellectual Property</u>. The Company owns, possesses, or can acquire on reasonable terms, all Intellectual Property necessary for the conduct of its business as now conducted or as described in the SEC Reports to be conducted, except as such failure to own, possess, or acquire such rights would not result in a Material Adverse Effect. Except as set forth in the SEC Reports, (i) to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties of any such Intellectual Property, except as such infringement, misappropriation or violation would not result in a Material Adverse Effect; (ii) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the Company&#8217;s rights in or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (iii) the Intellectual Property owned by the Company and to the knowledge of the Company, the Intellectual Property licensed to the Company has not been adjudged invalid or unenforceable, in whole or in part, and there is no pending or threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (iv) there is no pending or threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary rights of others, the Company has not received any written notice of such claim, and the Company is unaware of any other fact which would form a reasonable basis for any such claim; and (v) to the Company&#8217;s knowledge, no employee of the Company is in or has ever been in violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#8217;s employment with the Company or actions undertaken by the employee while employed with the Company, except as such violation would not result in a Material Adverse Effect. &#8220;<u>Intellectual Property</u>&#8221; shall mean all patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(p)<u>&nbsp;&nbsp;&nbsp;&nbsp;Insurance</u>. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company is engaged, including, but not limited to, directors and officers insurance coverage. The Company has no reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(q)<u>&nbsp;&nbsp;&nbsp;&nbsp;Transactions With Affiliates and Employees</u>. Except as set forth in the SEC Reports, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner, in each case in excess of $120,000, other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including equity awards under any equity incentive plans of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(r)<u>&nbsp;&nbsp;&nbsp;&nbsp;Sarbanes-Oxley</u>. The Company is in compliance with any and all requirements of the Sarbanes-Oxley Act of 2002 that are applicable to the Company, and any and all rules and regulations promulgated by the Commission thereunder, that are applicable to the Company and effective as of the date hereof and as of the Closing Date. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms. The Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;<u>Evaluation Date</u>&#8221;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(s)<u>&nbsp;&nbsp;&nbsp;&nbsp;Certain Fees</u>. Except for fees and commissions payable to Partner Capital Group, its successors, affiliates and assigns for the offering of Securities, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(t)<u>&nbsp;&nbsp;&nbsp;&nbsp;Private Placement</u>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(u)<u>&nbsp;&nbsp;&nbsp;&nbsp;Investment Company</u>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(v)<u>&nbsp;&nbsp;&nbsp;&nbsp;Registration Rights</u>. Other than with respect to the Company&#8217;s existing registration statements filed under the Securities Act, or as otherwise disclosed in the SEC Reports or <u>Schedule 3.1(v)</u> and other than each of the Purchasers, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(w)<u>&nbsp;&nbsp;&nbsp;&nbsp;Trading Market and Maintenance Requirements</u>. The Company&#8217;s Common Stock is registered pursuant to Section 12(g) of the Exchange Act. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the maintenance requirements of such Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(x)<u>&nbsp;&nbsp;&nbsp;&nbsp;Disclosure</u>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. .</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(y)<u>&nbsp;&nbsp;&nbsp;&nbsp;Tax Status</u>. Except for matters that could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, the Company (i) has made or filed all necessary federal, state, foreign and local income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(z)<u>&nbsp;&nbsp;&nbsp;&nbsp;Foreign Corrupt Practices</u>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(aa)<u>&nbsp;&nbsp;&nbsp;&nbsp;Accountants</u>. The Company&#8217;s accounting firm is Frazier &amp; Deeter, LLC. To the knowledge of the Company, such accountants, who the Company expects will express their opinion with respect to the financial statements to be included in the Company&#8217;s next Annual Report on Form 10-K, are a registered public accounting firm as required by the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(bb)<u>&nbsp;&nbsp;&nbsp;&nbsp;Acknowledgment Regarding Purchasers</u><u>&#8217;</u><u> Purchase of Securities</u>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#8217; purchase of the Securities. The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(cc)<u>&nbsp;&nbsp;&nbsp;&nbsp;Acknowledgement Regarding Purchaser</u><u>&#8217;</u><u>s Trading Activity</u>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(g) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&#8217; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(dd)<u>&nbsp;&nbsp;&nbsp;&nbsp;Regulation M Compliance.</u>&nbsp; During the applicable restricted period as defined in Regulation M, the Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(ee)<u>&nbsp;&nbsp;&nbsp;&nbsp;No General Solicitation</u>. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other &#8220;accredited investors&#8221; within the meaning of Rule 501 under the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(ff)<u>&nbsp;&nbsp;&nbsp;&nbsp;No Disqualification Events</u>. &nbsp;With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an "<u>Issuer Covered Person</u>" and, together, "<u>Issuer Covered Persons</u>") is subject to any of the "Bad Actor" disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a "<u>Disqualification Event</u>"), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(gg)<u>&nbsp;&nbsp;&nbsp;&nbsp;Other Covered Persons</u>. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Regulation D Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(hh)<u>&nbsp;&nbsp;&nbsp;&nbsp;Notice of Disqualification Events</u>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(ii)<u>&nbsp;&nbsp;&nbsp;&nbsp;No Additional Agreements</u>. For the avoidance of doubt, each Purchaser has the same rights with respect to the purchase of Shares as each of the other Purchasers other than as explicitly set forth herein or in any of the other Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">3.2<u>&nbsp;&nbsp;&nbsp;&nbsp;Representations and Warranties of the Purchasers</u>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)<u>&nbsp;&nbsp;&nbsp;&nbsp;Organization; Authority</u>. If such Purchaser is an entity, such purchaser duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with full right, corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. If such Purchaser is an entity, the execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate or similar action on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)<u>&nbsp;&nbsp;&nbsp;&nbsp;Own Account</u>. Such Purchaser understands that the Securities are &#8220;restricted securities&#8221; and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws) in violation of the Securities Act or any applicable state securities law. Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(c)<u>&nbsp;&nbsp;&nbsp;&nbsp;Purchaser Status</u>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be, an &#8220;accredited investor&#8221; as defined in Rule 501 under Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(d)<u>&nbsp;&nbsp;&nbsp;&nbsp;Experience of Such Purchaser</u>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(e)<u>&nbsp;&nbsp;&nbsp;&nbsp;General Solicitation</u>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(f)<u>&nbsp;&nbsp;&nbsp;&nbsp;Access to Information</u>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(g)<u>&nbsp;&nbsp;&nbsp;&nbsp;Confidentiality</u>. Other than to other Persons party to this Agreement, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect short sales or similar transactions in the future.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>ARTICLE IV.</b><br>
<b>&nbsp;&nbsp;&nbsp;&nbsp;OTHER AGREEMENTS OF THE PARTIES</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.1<u>&nbsp;&nbsp;&nbsp;&nbsp;Transfer Restrictions</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall have the rights of a Purchaser under this Agreement and the Registration Rights Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &#8220;accredited investor&#8221; as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and the Registration Rights Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser&#8217;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Shares pursuant to Rule 144 or pursuant to a Registration Statement, (iii) if such Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Securities and without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after such time if required by the Transfer Agent to effect the removal of the legend hereunder. The Company agrees that, at such time as such legend is no longer required under this Section 4.1(c), it will, no later than two Trading Days following the delivery by a Purchaser to the Transfer Agent of a certificate representing Shares or Warrant Shares issued with a restrictive legend, together with such documents or instruments as may be required by the Transfer Agent (such second Trading Day, the &#8220;<u>Legend Removal Date</u>&#8221;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company System as directed by such Purchaser.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each Purchaser, severally and not jointly with the other Purchasers, agrees that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&#8217;s reliance upon this understanding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.2&nbsp;&nbsp;&nbsp;&nbsp; <u>Furnishing of Information; Public Information.</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp; Until the earliest of the time that no Purchaser owns Securities, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp; At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144 (i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &#8220;Public Information Failure&#8221;) then, in addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to one percent (1.0%) of the aggregate Subscription Amount of such Purchaser&#8217;s Securities on the day of a Public Information Failure and on every thirtieth (30<sup style="vertical-align:top;line-height:120%;">th</sup>) day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required&nbsp; for the Purchasers to transfer the Underlying Shares pursuant to Rule 144, up to a maximum of three percent (3%) of the aggregate Subscription Amount of such Purchaser&#8217;s Securities on the day of a Public Information Failure. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &#8220;Public Information Failure Payments.&#8221;&nbsp; Public Information Failure<b> </b>Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure<b> </b>Payments are incurred and (ii) the third (3<sup style="vertical-align:top;line-height:120%;">rd</sup>) Business Day after the event or failure giving rise to the Public Information Failure<b> </b>Payments is cured.&nbsp; In the event the Company fails to make Public Information Failure<b> </b>Payments in a timely manner, such Public Information Failure<b> </b>Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&#8217;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.3&nbsp;&nbsp;&nbsp;&nbsp; <u>Securities Laws Disclosure; Publicity</u>. The Company shall no later than the 4<sup style="vertical-align:top;line-height:120%;">th</sup> Trading Day immediately after the Closing Date, issue a Current Report on Form 8-K, disclosing the material terms of the transactions contemplated hereby. From and after the issuance of such Current Report on Form 8-K to be filed in accordance with clause (i) of the preceding sentence, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser or its investment advisor, or include the name of any Purchaser or its investment advisor in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except: (a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.4<u>&nbsp;&nbsp;&nbsp;&nbsp;Shareholder Rights Plan</u>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;acquiring person&#8221; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.5<u>&nbsp;&nbsp;&nbsp;&nbsp;Non-Public Information</u>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to Company or any of its officers, directors, agents, employees or Affiliates, or a duty to the Company or any of its officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.6<u>&nbsp;&nbsp;&nbsp;&nbsp;Use of Proceeds</u>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes, including the payment of past and future legal fees related to patent infringement litigation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.7<u>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Purchasers</u>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<u>Purchaser Party</u>&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Parties, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Parties may have with any such stockholder or any violations by such Purchaser Parties of state or federal securities laws or any conduct by such Purchaser Parties which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.8<u>&nbsp;&nbsp;&nbsp;&nbsp;Reservation of Common Stock</u>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.9<u>&nbsp;&nbsp;&nbsp;&nbsp;Listing or Quotation of Common Stock</u>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, if required, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing or quotation and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.10<u>&nbsp;&nbsp;&nbsp;&nbsp;Warrant Shares</u>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the reseal of the Warrant Shares, or if the Warrant is exercised via cashless exercise and the Warrant Shares issued pursuant thereto may then be resold pursuant to Rule 144, or if a legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission), the Warrant Shares issued pursuant to any such exercise shall be issued free of all legends.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.11<u>&nbsp;&nbsp;&nbsp;&nbsp;Equal Treatment of Purchasers</u>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.12<u>&nbsp;&nbsp;&nbsp;&nbsp;Certain Transactions and Confidentiality</u>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company&#8217;s securities during the period commencing with the Discussion Time and ending at such time the transactions contemplated by this Agreement are first publicly announced as described in Section 4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Transaction Documents and the Disclosure Schedules.&nbsp; Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality to the Company or its subsidiaries with respect to the transactions contemplated by this Agreement after the issuance of the Current Report on Form 8-K as described in clause (i) of the first sentence of Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.13<u>&nbsp;&nbsp;&nbsp;&nbsp;Form D; Blue Sky Filings</u>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or &#8220;Blue Sky&#8221; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">4.14<u>&nbsp;&nbsp;&nbsp;&nbsp;Delivery of Securities After Closing</u>. The Company shall deliver, or cause to be delivered, the respective Securities purchased by each Purchaser to such Purchaser within two (2) Trading Days of the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>ARTICLE V.</b><br>
<b>&nbsp;&nbsp;&nbsp;&nbsp;MISCELLANEOUS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.1&nbsp;&nbsp;&nbsp;&nbsp; <u> Potential Risk Related to Auditor Consent and SEC Waiver Process.</u> The Company&#8217;s former auditor, MSL, P.A. (&#8220;Former Auditor&#8221;), resigned on November 1, 2024, due to its business combination with another accounting firm that elected not to retain the Company as a client. Although the Former Auditor previously completed the audits included in the Company&#8217;s filings with the Securities and Exchange Commission (the &#8220;SEC&#8221;), its consent may be required under Rule 436 of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), to include those audit reports in any registration statement. The Company has been informed that the Former Auditor may have limited or no ability to issue the required consent. If the Former Auditor cannot provide the consent, the Company plans to seek a waiver under Rule 437 of the Securities Act and the SEC&#8217;s related guidance. However, the SEC evaluates such requests on a case-by-case basis, and there is no assurance that a waiver will be granted. If the consent is unavailable and the SEC declines to grant a waiver, the Company may be unable to register the Shares within the time frame provided for in the Registration Rights Agreement, which could materially and adversely affect the Shares liquidity and value.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.2<u>&nbsp;&nbsp;&nbsp;&nbsp;Termination</u>.&nbsp; This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5<sup style="vertical-align:top;line-height:120%;">th</sup>) Trading Day following the date hereof; <u>provided</u>, <u>however</u>, that such termination will not affect the right of any party to sue for any breach by the other party (or parties).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.3<u>&nbsp;&nbsp;&nbsp;&nbsp;Fees and Expenses</u>. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.4<u>&nbsp;&nbsp;&nbsp;&nbsp;Entire Agreement</u>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.5<u>&nbsp;&nbsp;&nbsp;&nbsp;Notices</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<sup style="vertical-align:top;line-height:120%;">nd</sup>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.6<u>&nbsp;&nbsp;&nbsp;&nbsp;Amendments; Waivers</u>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchasers holding at least a majority in interest of the Shares then outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.7<u>&nbsp;&nbsp;&nbsp;&nbsp;Headings</u>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.8<u>&nbsp;&nbsp;&nbsp;&nbsp;Successors and Assigns</u>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.9<u>&nbsp;&nbsp;&nbsp;&nbsp;No Third-Party Beneficiaries</u>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.10<u>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law</u>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of Jacksonville, Florida, County of Duval. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of Jacksonville, Florida, County of Duval for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.10, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.11<u>&nbsp;&nbsp;&nbsp;&nbsp;Survival</u>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for the applicable statute of limitations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.12<u>&nbsp;&nbsp;&nbsp;&nbsp;Execution</u>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.13<u>&nbsp;&nbsp;&nbsp;&nbsp;Severability</u>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.14<u>&nbsp;&nbsp;&nbsp;&nbsp;Rescission and Withdrawal Right</u>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; <u>provided, however</u> that in the case of a recission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Purchaser&#8217;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.15<u>&nbsp;&nbsp;&nbsp;&nbsp;Replacement of Securities</u>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.16<u>&nbsp;&nbsp;&nbsp;&nbsp;Remedies</u>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agrees to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.17<u>&nbsp;&nbsp;&nbsp;&nbsp;Payment Set Aside</u>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.18<u>&nbsp;&nbsp;&nbsp;&nbsp;Independent Nature of Purchasers</u><u>&#8217;</u><u> Obligations and Rights</u>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in their review and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by the Purchasers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.19<u>&nbsp;&nbsp;&nbsp;&nbsp;Liquidated Damages</u>. The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.20<u>&nbsp;&nbsp;&nbsp;&nbsp;Saturdays, Sundays, Holidays, etc.</u>If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.21<u>&nbsp;&nbsp;&nbsp;&nbsp;Construction</u>. The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments hereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">5.22<b><u>&nbsp;&nbsp;&nbsp;&nbsp;WAIVER OF JURY TRIAL</u></b><b>. </b><b><u>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><i>(Signature Pages Follow)</i></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 45pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 75.5882%; margin-left: 0pt; margin-right: auto;">

		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 63.4%; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">PARKERVISION, INC.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">By:__________________________________________</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cynthia French</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</p>
			</td>
			<td style="vertical-align: top; width: 40.1%; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 4pt;"><u>Address for Notice:</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 4pt;">4446-1A Hendricks Avenue</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 4pt;">Suite 354</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 4pt;">Jacksonville, FL 32207</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 4pt;">Fax: (904) 732-6100</p>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 63.4%; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><u>With a copy to (which shall not constitute notice)</u>:</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Graubard Miller</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">The Chrysler Building</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">405 Lexington Avenue, 44<sup style="vertical-align:top;line-height:120%;">th</sup>&nbsp;Floor</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">New York, NY 10174</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Attention: David Alan Miller, Esq.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Fax: (212) 818-8881</p>
			</td>
			<td style="vertical-align: top; width: 40.1%; font-size: 11pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[PURCHASER SIGNATURE PAGES FOLLOW]</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[PURCHASER SIGNATURE PAGE]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">Name of Purchaser: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Signature of Authorized Signatory of Purchaser</i>: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">Name of Authorized Signatory: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">Title of Authorized Signatory: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">Email Address of Authorized Signatory: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Facsimile Number of Authorized Signatory: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Address for Notice of Purchaser:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 117pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 117pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Address for Delivery of Securities for Purchaser (<i>As a default, shares shall be issued via book entry at Equiniti Trust Company).</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 117pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 117pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Subscription Amount: $ <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Shares: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warrants: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Tax ID # <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[PURCHASER SIGNATURE PAGES CONTINUE]</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex_761250.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_761250.htm</title>
	<!-- Generated by ThunderDome Portal - 12/30/2024 7:09:59 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 10.2</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>REGISTRATION RIGHTS AGREEMENT</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">This Registration Rights Agreement (this &#8220;<u>Agreement</u>&#8221;) is made and entered into as of December [&#9679;], 2024, between ParkerVision, Inc., a Florida corporation (the &#8220;<u>Company</u>&#8221;), and each of the several purchasers signatory hereto (each such purchaser, a &#8220;<u>Purchaser</u>&#8221; and, collectively, the &#8220;<u>Purchasers</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &#8220;<u>Purchase Agreement</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company and each Purchaser hereby agrees as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Definitions</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</b> As used in this Agreement, the following terms shall have the following meanings:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">&#8220;<u>Advice</u>&#8221; shall have the meaning set forth in Section 6(d).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Effectiveness Date</u>&#8221; means, with respect to the Initial Registration Statement required to be filed hereunder, no later than May 20, 2025 (or, in the event of a &#8220;full review&#8221; by the Commission, no later than July 14, 2025) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 90<sup style="vertical-align:top;line-height:120%;">th</sup> calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a &#8220;full review&#8221; by the Commission, the 120<sup style="vertical-align:top;line-height:120%;">th</sup> calendar day following the date such additional Registration Statement is required to be filed hereunder); <u>provided</u>, <u>however</u>, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, <u>provided</u>, <u>further</u>, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Effectiveness Period</u>&#8221; shall have the meaning set forth in Section 2(a).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Event</u>&#8221; shall have the meaning set forth in Section 2(d).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Event Date</u>&#8221; shall have the meaning set forth in Section 2(d).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Filing Date</u>&#8221; means, with respect to the Initial Registration Statement required hereunder, on or before April 15, 2025 and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Holder</u>&#8221; or &#8220;<u>Holders</u>&#8221; means the holder or holders, as the case may be, from time to time of Registrable Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Indemnified Party</u>&#8221; shall have the meaning set forth in Section 5(c).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Indemnifying Party</u>&#8221; shall have the meaning set forth in Section 5(c).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Initial Registration Statement</u>&#8221; means the initial Registration Statement filed pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Losses</u>&#8221; shall have the meaning set forth in Section 5(a).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Plan of Distribution</u>&#8221; shall have the meaning set forth in Section 2(a).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Prospectus</u>&#8221; means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Registrable Securities</u>&#8221; means, as of any date of determination, (a) all Shares and Warrant Shares (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein) and (b) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; <u>provided,</u> <u>however</u>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) if (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders, as reasonably determined by the Company, upon the advice of counsel to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Registration Statement</u>&#8221; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">&#8220;<u>Rule 415</u>&#8221; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Rule 424</u>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;Selling Stockholder Questionnaire</u>&#8221; shall have the meaning set forth in Section 3(a).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><u>&#8220;SEC Guidance</u>&#8221; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission staff and (ii) the Securities Act and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Shelf Registration</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 18pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">(a)</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case, such registration shall be on another appropriate form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85% in interest of the Holders) substantially the &#8220;<u>Plan of Distribution</u>&#8221;&nbsp;attached hereto as <u>Annex A</u>; <u>provided</u>, <u>however</u>, that no Holder shall be required to be named as an &#8220;underwriter&#8221;&nbsp;without such Holder&#8217;s express prior written consent; <u>provided</u>, <u>further</u>, that in the event the Commission requires that a Holder be named as an &#8220;underwriter&#8221;&nbsp;and such Holder does not so consent, the Company shall not be required to include such Holder&#8217;s Registrable Securities in a Registration Statement, notwithstanding any provision to the contrary contained herein. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously effective under the Securities Act until all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &#8220;<u>Effectiveness Period</u>&#8221;). The Company shall request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Trading Day. The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. Eastern Time on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp; Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-1, subject to the provisions of Section 2(d) with respect to the payment of liquidated damages; <u>provided</u>, <u>however</u>, that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">a.</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">First, the Company shall reduce or eliminate any securities to be included by any Person other than a Holder;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">b.</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Second, the Company shall reduce Registrable Securities represented by Warrant Shares (applied, in the case that some Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares held by or issuable to such Holders, as determined in accordance with the definition of Registrable Securities, and</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">c.</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Third, the Company shall reduce Registrable Securities represented by Shares (applied, in the case that some Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Shares held by such Holders).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">In the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&#8217;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-1 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month period, or (vi) any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Registrable Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current public information requirement under Rule 144(c) (any such failure or breach being referred to as an &#8220;<u>Event</u>&#8221;, and for purposes of clauses (i), (iv) and (vi), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &#8220;<u>Event Date</u>&#8221;), then except during any period of time in which the Holders may sell the Registrable Securities pursuant to Rule 144 without volume limitations, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement with respect to the Registrable Securities affected by such Event and held by such Holder on such Event Date and each monthly anniversary thereof, up to a maximum of 6.0% of the aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for such Registrable Securities. If the Company fails to pay any liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 12% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any underwriter without the prior written consent of such Holder; <u>provided</u>, <u>however</u>, that in the event the Commission requires that a Holder be named as an &#8220;underwriter&#8221; and such Holder does not so consent, the Company shall not be required to include such Holder&#8217;s Registrable Securities in a Registration Statement, notwithstanding any provision to the contrary contained herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Registration Procedures</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">In connection with the Company&#8217;s registration obligations hereunder, the Company shall:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Not less than two (2) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. Notwithstanding the above, the Company shall not be obligated to provide the Holders advance copies of any universal shelf registration statement registering securities in addition to those required hereunder, or any Prospectus prepared thereto. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of such objection in writing no later than two (2) Trading Days after the Holders have been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <u>Annex B</u> (a &#8220;<u>Selling Stockholder Questionnaire</u>&#8221;) on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4<sup style="vertical-align:top;line-height:120%;">th</sup>) Trading Day following the date on which such Holder receives draft materials in accordance with this Section, whichever occurs first.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &#8220;review&#8221; of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus, <u>provided</u>, <u>however</u>, in no event shall any such notice contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available on the EDGAR system (or successor thereto) need not be furnished in physical form.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp; The Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay the filing fee required by such filing within two (2) Business Days of request therefor.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&#8217;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration Statement and Prospectus, subject to the payment of liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;Comply with all applicable rules and regulations of the Commission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(m)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(n)&nbsp;&nbsp;&nbsp;&nbsp;The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&#8217;s request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Registration Expenses</u>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company&#8217;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities) and (D) if not previously paid by the Company in connection with an issuer filing under FINRA Rule 5110, with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing or quoting of the Registrable Securities on any Trading Market as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(a)<u>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification by the Company</u>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&#8217; fees) and expenses (collectively, &#8220;<u>Losses</u>&#8221;), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&#8217;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(h).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(b)<u>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification by Holders</u>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, only to the extent arising out of or based solely upon: (x) such Holder&#8217;s failure to comply with any applicable prospectus delivery requirements of the Securities Act through no fault of the Company or (y) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&#8217;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or in any amendment or supplement thereto or (iii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), to the extent, but only to the extent, related to the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). In no event shall the liability of any selling Holder under this Section 5(b) be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(c)<u>&nbsp;&nbsp;&nbsp;&nbsp;Conduct of Indemnification Proceedings</u>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an &#8220;<u>Indemnified Party</u>&#8221;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &#8220;<u>Indemnifying Party</u>&#8221;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided, that, the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party; provided, that, the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">(d)<u>&nbsp;&nbsp;&nbsp;&nbsp;Contribution</u>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&#8217; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to contribute pursuant to this Section 5(d), in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;">The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Miscellaneous</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)<u>&nbsp;&nbsp;&nbsp;&nbsp;Remedies</u>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(b)<u>&nbsp;&nbsp;&nbsp;&nbsp;No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</u>. Except as set forth on <u>Schedule 6(b)</u> attached hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) (i) shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement and (ii) shall not prohibit the Company from filing a shelf registration statement on Form S-3 for a primary offering by the Company, provided that the Company makes no offering of securities pursuant to such shelf registration statement prior to the effective date of the Registration Statement required hereunder that includes all of the Registrable Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(c)<u>&nbsp;&nbsp;&nbsp;&nbsp;Compliance</u>. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to a Registration Statement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(d)<u>&nbsp;&nbsp;&nbsp;&nbsp;Discontinued Disposition</u>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &#8220;<u>Advice</u>&#8221;) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions of Section 2(d).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(e)<u>&nbsp;&nbsp;&nbsp;&nbsp;Piggy-Back Registrations</u>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&#8217;s stock option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities such Holder requests to be registered; <u>provided</u>, <u>however</u>, that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(e) that are eligible for resale pursuant to Rule 144 (without volume restrictions or current public information requirements) promulgated by the Commission pursuant to the Securities Act or that are the subject of a then effective Registration Statement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(f)<u>&nbsp;&nbsp;&nbsp;&nbsp;Amendments and Waivers</u>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of a majority of the then outstanding Registrable Securities. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; <u>provided</u>, <u>however</u>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6(f). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(g)<u>&nbsp;&nbsp;&nbsp;&nbsp;Notices</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(h)<u>&nbsp;&nbsp;&nbsp;&nbsp;Successors and Assigns</u>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(i)<u>&nbsp;&nbsp;&nbsp;&nbsp;No Inconsistent Agreements</u>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth on <u>Schedule 6(i)</u>, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(j)<u>&nbsp;&nbsp;&nbsp;&nbsp;Execution and Counterparts</u>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(k)<u>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law</u>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Purchase Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(l)<u>&nbsp;&nbsp;&nbsp;&nbsp;Cumulative Remedies</u>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(m)<u>&nbsp;&nbsp;&nbsp;&nbsp;Severability</u>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(n)<u>&nbsp;&nbsp;&nbsp;&nbsp;Headings</u>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or affect any of the provisions hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(o)<u>&nbsp;&nbsp;&nbsp;&nbsp;Independent Nature of Holders</u><u>&#8217;</u><u> Obligations and Rights</u>. The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">********************</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><i>(Signature Pages Follow)</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; width: 47.0588%; margin-left: 0pt; margin-right: auto;">

		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 101.9%; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>PARKERVISION, INC.</b></p>
			</td>
		</tr>
		<tr style="font-size: 11pt;">
			<td style="vertical-align: top; width: 101.9%; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">By:__________________________________________</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Cynthia French</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Chief Financial Officer</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[SIGNATURE PAGE OF HOLDERS TO PRKR RRA]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Name of Holder: __________________________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><i>Signature of Authorized Signatory of Holder</i>: __________________________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Name of Authorized Signatory: _________________________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">Title of Authorized Signatory: __________________________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[SIGNATURE PAGES CONTINUE]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: right; margin: 0pt;"><b><u>Annex A</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><u>Plan of Distribution</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Each Selling Stockholder (the &#8220;<u>Selling Stockholders</u>&#8221;) of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">ordinary brokerage transactions and transactions in which the broker&#8209;dealer solicits purchasers;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">block trades in which the broker&#8209;dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">purchases by a broker&#8209;dealer as principal and resale by the broker&#8209;dealer for its account;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">an exchange distribution in accordance with the rules of the applicable exchange;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">privately negotiated transactions;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">settlement of short sales;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">in transactions through broker&#8209;dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">a combination of any such methods of sale; or</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 54pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">any other method permitted pursuant to applicable law.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Selling Stockholders may also sell securities under Rule 144 under the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;), if available, rather than under this prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Broker&#8209;dealers engaged by the Selling Stockholders may arrange for other brokers&#8209;dealers to participate in sales. Broker&#8209;dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker&#8209;dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2121.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Because Selling Stockholders may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act, they will be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this prospectus. The Selling Stockholders have advised us that there is no underwriter or coordinating broker acting in connection with the proposed sale of the resale securities by the Selling Stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of securities of the common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex_761251.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html><head>
	<title>ex_761251.htm</title>
	<!-- Generated by ThunderDome Portal - 12/30/2024 7:12:02 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: right;"><b>Exhibit 10.3</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">THIS WARRANT HAS BEEN ACQUIRED AS AN INVESTMENT. NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>ParkerVision, Inc.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>WARRANT TO PURCHASE COMMON STOCK</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: right; margin: 0pt 0pt 0pt 42pt; text-indent: 31pt;">Number of Shares: [&#9679;](subject to adjustment)</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">Warrant No. <b><u>2024-[</u></b><u>&#9679;</u><b><u>]</u></b> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issue Date: December [&#9679;], 2024</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">ParkerVision, Inc., a Florida corporation (the &#8220;<i>Company</i>&#8221;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [<b><u>Investor]</u></b>, or its permitted registered assigns (the &#8220;<i>Holder</i>&#8221;), is entitled, subject to the terms set forth below, to purchase from the Company up to a total of <b><u>[</u></b><u>&#9679;</u><b><u>]</u></b> shares of common stock, $0.01 par value per share (the &#8220;<i>Common Stock</i>&#8221;), of the Company (each such share, a &#8220;<i>Warrant Share</i>&#8221; and all such shares, the &#8220;<i>Warrant Shares</i>&#8221;) at an exercise price per share equal to <b>$0.50 </b>per share (as adjusted from time to time as provided in <u>Section 9</u> herein, the &#8220;<i>Exercise Price</i>&#8221;), upon surrender of this warrant to purchase Common Stock (including any warrants to purchase Common Stock issued in exchange, transfer or replacement hereof, the &#8220;<i>Warrant</i>&#8221;) at any time and from time to time on or after the date hereof (the &#8220;<i>Original Issue Date</i>&#8221;) and through and including 5:30 P.M., New York City time, on the date that is five (5) years following the Original Issue Date (the &#8220;<i>Expiration Date</i>&#8221;), and subject to the following terms and conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 4pt;">1.<u>&nbsp;&nbsp;&nbsp;&nbsp;Definitions</u>. For purposes of this Warrant, the following terms shall have the following meanings:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Affiliate</i>&#8221; of any Person means any other Person directly or indirectly controlling, controlled by or under common control with such Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(b)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Commission</i>&#8221; means the United States Securities and Exchange Commission and any successor entity thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(c)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Closing Sale Price</i>&#8221; means, for any security as of any date, the last trade price for such security on the Principal Trading Market for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security immediately prior to 4:00 P.M., New York City time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no last trade price is reported for such security by Bloomberg Financial Markets, the average of the last bid and ask prices of any market makers for such security as reported on OTC Pink (also known as the &#8220;pink sheets&#8221;) by the OTC Markets, Inc. If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith judgment to determine the fair market value of such security on such date. The Board of Directors&#8217; determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(d)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Person</i>&#8221; means any natural person, corporation, firm, joint venture, partnership, limited liability company, association, enterprise, trust or other entity or organization, or any government or political subdivision or any agency, department or instrumentality thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(e)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Principal Trading Market</i>&#8221; means the trading market on which the Common Stock is primarily listed on and quoted for trading, and which, as of the Original Issue Date shall be the OTCQB Venture Market of the OTC Markets.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 36pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">(f)</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><i>&#8220;Securities Act</i>&#8221;&nbsp;means the Securities Act of 1933, as amended.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(g)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Trading Day</i>&#8221; means a day on which the Principal Trading Market is open for trading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(h)&#8220;<i>&nbsp;&nbsp;&nbsp;&nbsp;Transfer Agent</i>&#8221; means American Stock Transfer &amp; Trust Company, the Company&#8217;s transfer agent for the Common Stock (or any successor transfer agent the Company may engage), and the Company or its designee, with respect to the Warrants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">2.<u>&nbsp;&nbsp;&nbsp;&nbsp;Registration of Warrants</u>. The Company shall, or shall cause its Transfer Agent to, register this Warrant, upon records to be maintained by the Company or Transfer Agent for that purpose (the &#8220;<i>Warrant Register</i>&#8221;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any registered assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">3.<u>&nbsp;&nbsp;&nbsp;&nbsp;Registration of Transfers</u>. Subject to compliance with all applicable securities laws, the Company shall, or shall cause its Transfer Agent to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, and payment of all applicable transfer taxes. Upon any such registration of transfer, a new warrant to purchase Common Stock in substantially the form of this Warrant (any such new warrant, a &#8220;<i>New Warrant</i>&#8221;) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the New Warrant that the Holder had in respect of this Warrant. The Company shall, or shall cause its Transfer Agent to, prepare, issue and deliver at the Company&#8217;s own expense any New Warrant under this <u>Section 3</u>. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder of this Warrant for all purposes, and the Company shall not be affected by any notice to the contrary.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 0pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">4.</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><u>Exercise and Duration of Warrants</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;All or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant at any time and from time to time on or after the Original Issue Date and through and including 5:30 P.M. New York City time, on the Expiration Date. At 5:30 P.M., New York City time, on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be void and of no value and this Warrant shall terminate and no longer be outstanding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as <u>Schedule 1 </u>hereto (the &#8220;<i>Exercise Notice</i>&#8221;), completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is being exercised (which may take the form of a &#8220;net share exercise&#8221; if so indicated in the Exercise Notice pursuant to <u>Section 10</u> below), and the date on which the last of such items is delivered to the Company (as determined in accordance with the notice provisions hereof) is an &#8220;<i>Exercise Date</i>.&#8221; The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant to the Holder evidencing its right to purchase the remaining number of Warrant Shares. For the avoidance of doubt, the Company may not substitute, and the Holder may not request, a cash payment in satisfaction of the Company&#8217;s obligation to issue and deliver Warrant Shares pursuant to an Exercise Notice, other than as specified in Sections 5(a), 9(c) or 12 of this Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 0pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">5.</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><u>Delivery of Warrant Shares</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Upon exercise of this Warrant, the Company shall promptly (but in no event later than two (2) Trading Days after the Exercise Date), upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company (&#8220;<i>DTC</i>&#8221;) through its Deposit Withdrawal Agent Commission system, or if the Transfer Agent is not participating in the Fast Automated Securities Transfer Program (the &#8220;<i>FAST Program</i>&#8221;) or if the certificates are required to bear a legend regarding restriction on transferability, issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise. The Holder, or any Person permissibly so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder&#8217;s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the case may be.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;To the extent permitted by law, the Company&#8217;s obligations to issue and deliver Warrant Shares in accordance with and subject to the terms hereof (including the limitations set forth in <u>Section 11</u> below) are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall limit the Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in Section 5(d) hereof, the Warrants Shares to be issued under this Warrant shall be issued without any restrictive legend. The Company shall issue irrevocable instructions to its Transfer Agent, to issue Common Stock in the name of the Holder for the Warrant Shares and the Company warrants that the Warrant Shares shall be freely transferable on the books and records of the Company. Notwithstanding anything herein to the contrary, the Warrant Shares shall not be required to contain any legend if such shares are eligible for sale under Rule 144 of the Securities Act, or if such legend is not required under other applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the United Stated Securities &amp; Exchange Commission). The Company shall cause its counsel to issue a legal opinion to the Company&#8217;s transfer agent or the Holder if required by the Company&#8217;s transfer agent to effect the removal of the legend hereunder, or if requested by the Purchaser, respectively, provided that such legend is not required pursuant to the foregoing provisions of this paragraph. The Company agrees that at such time as such legend is no longer required under this section (including, without limitation, following the effective date of the Registration Statement), it will, no later than the earlier of (i) two (2) Business Days and (ii) the number of Business Days comprising the Standard Settlement Period (as defined below) following the delivery by the Purchaser to the Company or the Company&#8217;s transfer agent of a certificate representing Warrant Shares issued with a restrictive legend (such date, the &#8220;Legend Removal Date&#8221;), deliver or cause to be delivered to the Holder such shares that are free from all restrictive and other legends in such manner as directed by the Holder. The Company may not make any notation on its records or give instructions to the Company&#8217;s transfer agent that enlarge the restrictions on transfer set forth in this section. The Company shall pay all reasonable fees and expenses (including the reasonable fees and expenses of legal counsel) relating to the removal of the restrictive legends. As used herein, &#8220;Standard Settlement Period&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s Principal Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Warrant Shares, as the case may be, issued with a restrictive legend.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;If the Company files a registration statement to register any of its Common Stock or other registerable securities, the Company shall also include the Securities in such new registration statement in order to cover the resale of the Securities by the Buyer. If any Warrant Shares are issued and are neither registered for sale nor eligible for sale pursuant to Rule 144 under the 1933 Act, they shall be issued in certificated or restricted book-entry form and (subject to Section 5 (c) hereof) shall bear a restrictive legend substantially similar to the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 6pt;"><b>THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, UNLESS SOLD PURSUANT TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2) AN OPINION OF HOLDER</b>&#8217;<b>S COUNSEL, IN A CUSTOMARY FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">6.<u>&nbsp;&nbsp;&nbsp;&nbsp;Charges, Taxes and Expenses</u>. Issuance and delivery of certificates for shares of Common Stock upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; <u>provided</u>, <u>however</u>, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any certificates for Warrant Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">7.<u>&nbsp;&nbsp;&nbsp;&nbsp;Replacement of Warrant</u>. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and reasonable indemnity and surety bond, if requested by the Company. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company&#8217;s obligation to issue the New Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">8.<u>&nbsp;&nbsp;&nbsp;&nbsp;Reservation of Warrant Shares</u>. The Company covenants that it will at all times while this Warrant is outstanding reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of this entire Warrant (less the number of Warrant Shares so issued and delivered), free from preemptive rights or any other contingent purchase rights of persons other than the Holder (taking into account the adjustments and restrictions of <u>Section 9</u>). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized and issued, and fully paid and nonassessable. The Company will take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Stock may be listed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">9.<u>&nbsp;&nbsp;&nbsp;&nbsp;Certain Adjustments</u>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this <u>Section 9</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)<u>&nbsp;&nbsp;&nbsp;&nbsp;Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii) combines its outstanding shares of Common Stock into a smaller number of shares of Common Stock or (iv) issues by reclassification of shares of capital stock any additional shares of Common Stock of the Company, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately before such event and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution; <u>provided</u>, <u>however</u>, that if such record date shall have been fixed and such dividend is not fully paid on the date fixed therefor, the Exercise Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Exercise Price shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends. Any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(b)<u>&nbsp;&nbsp;&nbsp;&nbsp;Fundamental Transactions</u>. If, at any time while this Warrant is outstanding (i) the Company effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving entity or the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company effects any sale to another Person of all or substantially all of its assets in one or a series of related transactions, (iii) pursuant to any tender offer or exchange offer (whether by the Company or another Person), holders of capital stock who tender shares representing more than 50% of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for payment, (iv) the Company consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than the 50% of the voting power of the capital stock of the Company or (v) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by <u>Section 9(a) </u>above) (in any such case, a &#8220;<i>Fundamental Transaction</i>&#8221;), then following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein (the &#8220;<i>Alternate Consideration</i>&#8221;). The Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver to the Holder, such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(c)<u>&nbsp;&nbsp;&nbsp;&nbsp;Number of Warrant Shares</u>. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) of this <u>Section 9</u>, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(d)<u>&nbsp;&nbsp;&nbsp;&nbsp;Calculations</u>. All calculations under this <u>Section 9 </u>shall be made to the nearest cent or the nearest share, as applicable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(e)<u>&nbsp;&nbsp;&nbsp;&nbsp;Notice of Adjustments</u>. Upon the occurrence of each adjustment pursuant to this <u>Section 9</u>, the Company at its expense will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company&#8217;s transfer agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(f)<u>&nbsp;&nbsp;&nbsp;&nbsp;Notice of Corporate Events</u>. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters into any material definitive agreement contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then, except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice of such transaction at least ten (10) days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction; <i>provided</i>, <i>however</i>, that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, if the Company enters into any material definitive agreement contemplating or solicits stockholder approval for any Fundamental Transaction contemplated by <u>Section 9(c)</u>, other than a Fundamental Transaction under clause (iii) of <u>Section 9(c)</u>, the Company shall deliver to the Holder a notice of such Fundamental Transaction at least fifteen (15) days prior to the date such Fundamental Transaction is consummated. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of its subsidiaries, the Holder shall keep such information confidential until the Company shall file such notice with the Commission pursuant to a Current Report on Form 8-K.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">10.<u>&nbsp;&nbsp;&nbsp;&nbsp;Payment of Exercise Price</u>. Notwithstanding anything contained herein to the contrary, if a registration statement covering the Warrant Shares that are the subject of the Exercise Notice, or an exemption from registration, is not available for the resale of the Warrant Shares to the public, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a &#8220;net share exercise&#8221;, in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">X = Y [(A-B)/A]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">where:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">&#8220;X&#8221;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;equals the number of Warrant Shares to be issued to the Holder;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">&#8220;Y&#8221;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">&#8220;A&#8221;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the Closing Sale Price of the shares of Common Stock on the date immediately preceding the Exercise Date; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: -27pt;">B&#8221;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a &#8220;cashless exercise&#8221; transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: justify; margin: 0pt;">Notwithstanding anything herein to the contrary, on the Expiration Date, any remaining part of this Warrant shall be automatically exercised via net share exercise pursuant to this <u>Section 10</u> without any action being required on the part of the Holder. The Company shall promptly deliver to the Holder the calculation made pursuant to the preceding sentence, together with any Warrant Shares to which such Holder is entitled.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">11.<u>&nbsp;&nbsp;&nbsp;&nbsp;Limitations on Exercise</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that, following such exercise (or other issuance), the total number of shares of Common Stock then beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#8217;s for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the &#8220;<i>Exchange Act</i>&#8221;), does not exceed 4.99% of the total number of then issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise), it being acknowledged by the Holder that the Company is not representing to such Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder and such Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this <u>Section 11(a) </u>applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder and its Affiliates) and of which a portion of this Warrant is exercisable shall be in the sole discretion of a Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder and its Affiliates) and of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination under this <u>Section 11(a)</u> as to any group status shall be determined by the Holder in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <u>Section 11(a)</u>, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&#8217;s most recent Form 10-Q or Form 10-K, as the case may be, (y) a more recent public announcement by the Company that contains such number of shares or (z) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of the Holder, the Company shall within one (1) Trading Day confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. By written notice to the Company, which will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, the Holder may waive the provisions of this <u>Section 11(a) </u>(but such waiver will not affect any other holder) to change the beneficial ownership limitation to such percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant as the Holder shall determine, in its sole discretion, and the provisions of this <u>Section 11(a) </u>shall continue to apply. Upon such a change by a Holder of the beneficial ownership limitation from such 4.99% limitation to such other percentage limitation, the beneficial ownership limitation may not be further waived by such Holder without first providing the minimum notice required by this <u>Section 11(a)</u>. Notwithstanding the foregoing, at any time following notice of a Fundamental Transaction under <u>Section 9(g)(ii) </u>with respect to a <u>Section 9(c)(iii) </u>Fundamental Transaction, the Holder may waive and/or change the beneficial ownership limitation effective immediately upon written notice to the Company and may reinstitute a beneficial ownership limitation at any time thereafter effective immediately upon written notice to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, including <u>Section 11(a)</u>, the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise this Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect to such exercise, would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#8217;s for purposes of Section 13(d) of the Exchange Act, to exceed 14.99% of the total number of issued and outstanding shares of Common Stock of the Company following such exercise, or (ii) the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#8217;s for purposes of Section 13(d) of the Exchange Act to exceed 14.99% of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this <u>Section 11(b)</u>, the aggregate number of shares of Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#8217;s for purposes of Section 13(d) of the Exchange Act shall include the shares of Common Stock issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock), are subject to a limitation on conversion or exercise analogous to the limitation contained herein and are beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder&#8217;s for purposes of Section 13(d) of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;This <u>Section 11 </u>shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in <u>Section 9 </u>of this Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">12.<u>&nbsp;&nbsp;&nbsp;&nbsp;No Fractional Shares</u>. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">13.<u>&nbsp;&nbsp;&nbsp;&nbsp;Notices</u>. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile or confirmed e-mail at the facsimile number or e-mail address specified in the books and records of the Transfer Agent prior to 5:30 P.M., New York City time, on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or confirmed e-mail at the facsimile number or e-mail address specified in the books and records of the Transfer Agent on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying next business day delivery, or (iv) upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">14.<u>&nbsp;&nbsp;&nbsp;&nbsp;Warrant Agent</u>. The Company shall initially serve as warrant agent under this Warrant. Upon thirty (30) days&#8217; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#8217;s last address as shown on the Warrant Register.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 11pt;">

		<tr style="font-size: 11pt;">
			<td style="width: 0pt; font-size: 11pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">15.</p>
			</td>
			<td style="vertical-align: top; font-size: 11pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;"><u>Miscellaneous</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(a)<u>&nbsp;&nbsp;&nbsp;&nbsp;No Rights as a Stockholder</u>. The Holder, solely in such Person&#8217;s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&#8217;s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">(b)<u>&nbsp;&nbsp;&nbsp;&nbsp;Authorized Shares</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 72pt;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(c)<u>&nbsp;&nbsp;&nbsp;&nbsp;Successors and Assigns</u>. Subject to the restrictions on transfer set forth in this Warrant and compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(d)<u>&nbsp;&nbsp;&nbsp;&nbsp;Amendment and Waiver</u>. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holders of Warrants representing no less than a majority of the Warrant Shares obtainable upon exercise of the Warrants then outstanding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(e)<u>&nbsp;&nbsp;&nbsp;&nbsp;Acceptance</u>. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(f)<u>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law; Jurisdictio</u>n. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF JACKSONVILLE, FLORIDA, COUNTY OF DUVAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(g)<u>&nbsp;&nbsp;&nbsp;&nbsp;Headings</u>. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">(h)<u>&nbsp;&nbsp;&nbsp;&nbsp;Severability</u>. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 216pt;">PARKERVISION, INC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 180pt; text-indent: 36pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;____________________________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 162pt; text-indent: 54pt;">Name:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cynthia French</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 180pt; text-indent: 36pt;">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex_761252.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<html><head>
	<title>ex_761252.htm</title>
	<!-- Generated by ThunderDome Portal - 12/31/2024 12:29:35 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-indent: 99pt; text-align: right;"><b>Exhibit 10.4</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b><u>Schedule of Investors</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" class="finTable" style="width: 100%; font-size: 11pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">

		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; width: 17%; border-top: 2px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Date</b></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; width: 34%; border-top: 2px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: left;"><b>Investor</b></p>
			</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Subscription Amount</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; padding-bottom: 1px; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Shares</b></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; padding-bottom: 1px; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Warrants</b></p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; padding-bottom: 1px; border-top: 2px solid black; border-bottom: 1px solid black; width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; width: 17%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt;">December 24, 2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; width: 34%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt;">Harold Wrobel</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">2,779,201</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">5,558,402</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">1,000,000</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; width: 17%;">December 24, 2024</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; width: 34%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt;">Key Properties, Inc.</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">200,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">400,000</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">-</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; width: 17%;">December 30, 2024</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; width: 34%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt;">Thomas Staz Revocable Trust</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid black;">$</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid black;">2,020,799</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".amt.4" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid black;">4,041,598</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".amt.5" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 1px solid black;">1,000,000</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; background-color: rgb(255, 255, 255);">
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 2px solid black; width: 17%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; font-variant: normal; margin: 0pt;"><b>Total</b></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 2px solid black;">$</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 2px solid black;">5,000,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".amt.4" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 2px solid black;">10,000,000</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; border-bottom: 2px solid black;">&nbsp;</td>
			<td id=".amt.5" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; margin-left: 0pt; border-bottom: 2px solid black;">2,000,000</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 11pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid black;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>prkr-20241224.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/31/2024 6:22:14 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:prkr="http://www.prkr.com/20241224" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.prkr.com/20241224">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prkr-20241224_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prkr-20241224_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prkr-20241224_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.prkr.com/20241224/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="prkr_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>prkr-20241224_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/31/2024 6:22:14 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.prkr.com/20241224/role/statement-document-and-entity-information" xlink:href="prkr-20241224.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.prkr.com/20241224/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>prkr-20241224_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/31/2024 6:22:14 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>prkr-20241224_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/31/2024 6:22:14 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.prkr.com/20241224/role/statement-document-and-entity-information" xlink:href="prkr-20241224.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.prkr.com/20241224/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45874880829952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 24, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">PARKERVISION, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Dec. 24,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-22904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">59-2971472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">4446-1A Hendricks Avenue Suite 354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Jacksonville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">32207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">732-6100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000914139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  )@9]9!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M  F!GUGG#QTV[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    (  F!GUF97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ "8&?6;@T
M4(CO P  [PX  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    (  F!GUF?H!OPL0(  .(,   -
M  "  3,,  !X;"]S='EL97,N>&UL4$L! A0#%     @ "8&?69>*NQS
M$P(   L              ( !#P\  %]R96QS+RYR96QS4$L! A0#%     @
M"8&?63JJHN=  0  / (   \              ( !^ \  'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    (  F!GUDD'INBK0   /@!   :              "
M 641  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  F!
MGUEED'F2&0$  ,\#   3              "  4H2  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  )03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="prkr20241230_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prkr.com/20241224/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>prkr-20241224.xsd</File>
    <File>prkr-20241224_def.xml</File>
    <File>prkr-20241224_lab.xml</File>
    <File>prkr-20241224_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="prkr20241230_8k.htm">prkr20241230_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "prkr20241230_8k.htm": {
   "nsprefix": "prkr",
   "nsuri": "http://www.prkr.com/20241224",
   "dts": {
    "schema": {
     "local": [
      "prkr-20241224.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "prkr-20241224_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "prkr-20241224_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prkr-20241224_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "prkr20241230_8k.htm"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 19
   },
   "report": {
    "R1": {
     "role": "http://www.prkr.com/20241224/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prkr20241230_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prkr20241230_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.prkr.com/20241224/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001437749-24-038601-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-038601-xbrl.zip
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MCW>^N:>3?:?=?Y*?%^ +\[X_H3QC$BL",_':M3])I5+,699L*(#F 3/T?%"
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MVRZDV:HZN*-LO-01A(()CK7)4?0(6OE@EY>2NP4KL'/P7CI/(+=A0F!LINC
MQ&Y33C6JIDU=[*0),D.\*[L"13WEL/S>)/%OMB?3R]4N.,.PDFO=.'[3Q% P
MV80,JT0(HF(J1XS- 8@'?^(Q/!KFZO#M*2;AIB8-(RAL$N-,G^<NYC@,#<@V
M/0T0(6077VOPB_UW+ %!>8;$O87$YU:_RNJ#W-STBJP,;F-TNQBE+&E^PYNY
M5U@];FDC[I\AW..RREM&YN*S?)G*=A@UM6$')R%(-U BS%+A]1Y&S#>!$$^-
M\$R-N.2&(YWPZGB8@%86]!!7\5-IGE[; -X@,AF93HRE"JQ3H*)3$HXLXU7R
M^;R%XSST0_FCMC(.-9\C<I/?_SKRNC2)=E\:Z.$M$7B! 3,T]M,[6N$^[RNF
M!84A0%D4WAU N_S&R)XB/4SI5.2-KC MY1XTB'#V=6%K5_VND, CDX$6YY,6
M- P,\8--1GE=,EHBYS:3?0>7OG=F@BRV+S>!%:P986@J4)P8D;DPW]$2*=(G
M+$1SFK7GM]P8"'=U5^^K^@K,GO.\M_525W"',TK=9TWD:5V^?N/DH)-SOA;!
M["VMI\EK!RUSL:U(<!2-3#90N9"-?ISZE@DI[E-,O[O.LP;N8MHE] (_?$M&
ME7B[K==93LW^T)7P(;]8=&_O$17D-,G>DZWIML<FZ&E";C7B3$>1,,E=Z- Z
M:ELJ4*E?%[K^9)LK2%&GYBH+<2<@K'KM.HFH'0-:>#,%SVUS),NU!G%?Z$0'
M=5Y!-^8PVNEZ6'2F586?\0!]/$:--X/+4)!TRN_,];66+)^ODG62:@EY;1]Z
MBS?#),J$C/)RF-K(6M9H'/^8Y,4E%7$P'H0J+S14RATR"Z8(E*@JD^"[K:<(
M/NLJ!-.4?U@432AX\7KW'%"(:B44C:UHQOF5:@U[<]94 H*)%I&&P.DFK.B[
MQ49V'\9;)'J!YYK-1ILFAMJQ]QH2G*-)3$U5"V=OP7K*3<-H"EJ[]T3&9=(.
M<ZQ'YDZFI)W[U_0.-EWDR0_A#A[?17]/F<6)<B(X7",WW+X4Q[!48Y2<C:*!
MG8UJ'T/H+#.<LH'#B/H/P\DIV;0P:25W)V-QYG&TYGG]]!^WRYO&_%+:#VM*
MBMF<\9%-(:CB"A^S/^ZZZ*$.UG-.V#3MY,L&>'A^=L 6I.![Y*U-F2B(\VP%
MTBOLUN; 2)2UI\;#Y@TMG&K!QX9$ :;.D D4B;Q('$R7KHLXBU1\D4L$64V3
M+2]?WHQ&QR'6-W?1 X$3>31EP/_5KGQK$?^P-WIM?N36Y" LJVS)M&_1>^"S
M<7,Y/P+-U[KN^*96%> ;\,F<9453DOV)6<35&Z@+-NFB;HO5@46ZK[P0R2]5
M<WY[Q7#G'!//6IBALKYJW2UT*3J4%=*_55+P:3_M[6?(SPO9=&RNI$AU+^^6
MDIY]D!,*%Y$8GBAU8ZN1K7:QSE9S ("7W"#N*1Q)*5&$V=^_Y)D_+!CO)S[Q
MJQR4>+TPMMQI(1H_"$!BQ X\][6[W8E#9:7MZQ9_*!5H2!+"#S(B1VV[+8SN
M)3 )*:6+V=5V>%9P8P@%E3(]/QLN5/#CWI#/+/[B(IOR 2<G'P$7GP2RD)QM
M-$S.+3!8A99F\K=0*(!P(TT:@H9,6GRT37E3!#=?HYX0_.EDTJ#CBL.L$$SB
MGB(S")(95JAA?  ?1%O HT*6!/<B:S',@A%8\1FW7FP'0^V#'<8H+V8ESU 1
MKPF)[A!K?Z/$8^LWN'&P&3073%G?2-X\E<1Q;.*S4ABE40[GX&B3#^V5$/[V
M,O[3:3XI2<UI"IW0705AONC#*:;Y%;I*H9'VPGO&#C8D/3H"[]J$"*:I1&IZ
M3S(>M26\IKGBP$X0:,5'!%YU:A!(,1P';"6UWX)T"H?:T&T0&!V.F=1O]H%S
M^.G'1\YI7ZV8;Y-*DI\/8Y3<9J/1FE4.MHQFN$.819A?N9^9&0Q/BR;CXPQ=
MV6DMFY\L(#AJ-!OC?%8W>6\G)DK'@5)RQF'L&>X7;(4#1SC/.IWSHB*T#%7X
M:)9C$+H9N@7KJTM2(__TZ%ZG9'"G@26\3CSB>LBW4\X.%.WZL Z%54W!9FIP
MH&E0P>;E@2]6XP)"9\\@>%5PJ0-F$^S:.0ET12\A/\2$].%^QNREN>O5_A<B
M9IR.X.[8:/4.'PZ7@+?0=L3/M+6W;=G7(^XXW7/-0P/5:+-=5O.!XMM80<SF
MM,8*.H0E/S>Y]]NE$36S1\@^J1)"F[8@@Q:WXG7J0-4S'RU.;34AI1@HXRS5
M*BHQ;A7%["Y02.3D;4LIBT.5J@_42P:(\#?0:Y%-#&1U^$"0OLVXZ*@ )0U!
M@'BGZ;RH!+>&:$1N;>OC4G5S;;""6WV((>G3:P,UE.KC;;1P;%-%,&>\QS::
MZ!*Y8!#[YE2-P\85.H_T^JU@Y;F))KL^=RG(78="5#_O-$@5"00?A!'!U'AS
M4,0 WF)9S;++FCM0@:E0L"7RZZ!U8Y7MJ2MMM[I/%*(/6/KHV5CIYQ07+?,P
MTBIO]* 9NPZ&3C$/MC2Y@(U7(B)9->N"D<XHV@Z'Z&\W;A3O#%IP.:&$U739
M8?[SYH/@3F)GCE"@ !G\&IXVKQ!4)_L7C1P>[4S'.W:.L>?([(:#<^:!/B%B
MP8 )ME"$KZ_\P#_;9:NO0W87'VW0V=(IEDT( R'UH387_1ZJO$&8<+BA1QL8
M.&N.G]=JCFP,4W>22VR-U<=1[4,O)5T 1L ":W#$.+J5;$>FACEVSE.?RUA3
M1D IF&D0:!3.O4]W5/&%JO[XO''LGD\IN'FN0,(,P5)499MU#$3))?N)(7/Y
ME;M-HU-X42P"KXTGH]\:4$ZZIORHJ8_7',D8EAC489"&'-YDC(6)E[F8D=S1
ML#\*_#1X1:24H"469/MEON+<WVJ)R6VBE[D*EF5,)93##+/;5]JTE_P?&A^=
M>44/I($OP85)'N?'-C28G'G'$7/G7/CIHJ!Z73W F'3>%>&7#LS%HDJ?2I_:
M&[!T$JCKI6^IZ->" QH4E_!OH94ODEWIS[-SL5R)DEE4.1U>%:TY.T%VK,/L
M;K]D8P6<X-W.Z<Z*N@D)FQ*72JQD**BG->],46+_I\96T,IT754-B:N#,;H?
M7V7G$NFYP/C-C70IX:NY"J*42)TN00%3G,VCD%UWTW2-.)&6TINZHC4*Y?U:
MA+!;DCN[(F[?HCE<:"3157VRYN?U#.3*EO =<#UHX,\/_5JJ3^(OTEN5C:;B
MGUM%HT.*V2;;;+E>]-+@+KGK'2JU'$5ZRW$=O&[XM7US-0AQ>98-G>",BT2Y
MJ',@REC:!1^; L\5Y FU*1 L_*T&;IBK"]R"$RL6H$@Y),55"JK&O(*SVWE5
ME.[&K_U ?_@J2U-9*95E<=_OID(P4S&J2EFRZF[/Q :",G-)LF19YCU @URR
MZGD>GZ!ENU3V+_J+LF4D?M.>A*:!L9!FP>SC/A)T#9BR\$XT]70QTX!S,I3,
MKNJR:.J*Y]*'3DEM41HKJ,K<5&-^LM0LUTG-?;\:,'V'L&!#C)$2IUF"18X<
M-'UEV(<-WJ3BK4I?@!6Z-)'*SM-X7BQAEI*+/"L=P8O=1[82.9N/"U+L18,A
MI6:6X;!P?Z3)>8-B0OXH*=<E%Q"B:*Q_D4N8;=L#,QAM+DYIR_;A!:P)8<-S
MC%3F$NAP,2;_\2R97,!O)U0&SJ_, ';*6F,EOA(3=/6'8L)!AG]FS;1>MMKP
M78H4K[*VX]26#?SXJ,_W[G=Z/D(\$*'4!T?29L<&%":P#$N,<I/07V PKFTI
MNV-S-"ER$*8^#(^;H&[ R*++%C55/U"A E52T!M6TU(J1R*CILK+JQRV%994
ME&4(Y:2YF^+DLV2F?\! ISR-_.^DS,E.M47RK:^=;S&./Z'LGD8>6]$BJ#/=
MCTGBX\(A:0+^BJM4 BF,SQ (+C%:X3\L.*A66&H %+( B_BAU'5[RKJ*#$:/
MW()9D4&Y-_$*2&&P!@7!AOQ\&,D?/MQ2(@X 6BKY,0/N:TO72(951KD#A?%K
MN 7Q\P7#89/<J0LJ[C=T=:; OV>VM[5BA"8^Z>%42]\0OXTIO]$Z:[7.?)W6
M.?&Q[F/>M$.M W*BI7U%N\;TY6U[-?ZMEL73YI?8H!C(M'' 74<C9F6UOFJD
M2 2>\O$.(&?.09\WU?<57@/%B#J4\IYV[_]J!I 5*NX2,^,A6V,L6>P%C*=-
MP (UEX<9TEPA%>/$L2_,ZZDGHI)CWAO*YL#@@:G6'9BSHF-C>T14/W$<.'&V
MXD+.B72 [7/Z(8([L&JS  E(MV&P."+98I2R[/BU)F;&*^LV?!_V!L]<^W#1
M3BU5>OT:CTQ#EV%-2;D[?)CTYR)S/*[,3J5/<[DO>@8HFJ4O9G'#9?AV_W?$
MR3VCA)7&7I=*9T]R"7Y.26S#J#"X=83BD8?J,( >1-)SS9R.)]A(VK]:O&>4
M8ISI0BZ1ZI<E?EVQU:M<18L<5H?+5484-[!KQ5C)B6*4+G(03VPZD&$[> /$
MBN$UMH2 4H<I\R][+FW+*BA&,LUDM%(EL"DV<@/E1KV61 )V)SD'2Y2VLIA#
MZ<'\]$[C<F5H5KE:4^+C%3V4*Z$C'K'H_8W&U/VK:E."-U9S8@ _8+F^09O*
M07(_"= <A"_VNA7>R[U6:HMGZ4*I*[LRNO86*9W;QA4)-'F'["LF$Q!^+6D"
M<"^]\2*ZU,>"&)'43+D$/ \-Z.BB#*;I+H^[TQ0]=?!,]VH?#<T(H"&+ /S!
M(<SQM=;F*6*AEX#V>3)>;2YZD&S&NNF*),Z6%0+R<IUL=(1;D5,\0T3&G=FS
MPL#Z6=WXY]' GQHL9?P0.>W8UPRWV50K[BDNE;M'W]JCH"/BP.&V>/:X&JA&
M0CTCIE-FKJ\Y_ C_QDUH"W+[B_YK+:G%GK03>*?;;/O??ATO5VWVCWUO ;#9
MTA<^JVWOH!H?G\(UPJ7)O!,KMI7%S6H>T[-!\@CB'"2!+]!KA*@F#;W*;29=
M&-0RZO7X<3/O0*YQ\*D[((S65.J2?E61B@1\2Z)^6!EYOS%SC$0<V(C=YXM-
MWA?A,Q5'VML6W$U./UI$Z<J4,7[5UG!X7:P^^"[VO'4YY(3)*3@BHW <F9_&
M.*E2(R@KZZ?C1DB"F9P^((&5L.E&P)T11,RY18(M4;H_IQ%80T^9?:2JVC'1
MTI6FDCC)TL]JGF?BS]!BMV[50\HX+B.@$'/>7.()0;]HY1<!$LE=567SG**;
MBVL^H39*Z?:3N[S%\">E-//)1567]3E,%)Z"!Q=@8_FJW\*^J5KX&V,:C>G%
M>F,:SIA/, \ #W@"V>.A?S8M$R%-ZG/J)61 V=RLK"T$:*$(5$Z:U1ST0O!#
MT;Z7YC-2.Y?-$?_IZ/H6S7*J*(;)LNU@@KB.T[K.5+ 2=Z= MV;G:$*[1 <V
M/2$V7\<(C@0X4\>%0+N(T23RR@*"@&,%MQH&):I:A#G;[80;<IEEQW&"#4TE
MG=B NKQB])!6#PR?0Q. T VLB6.=H-]0J;$D8!Q3J-(GN*N(Z4T_=>OE"QC[
M03^"VH2^B^M:G* XIR 751 B@7,KX>]V$]RB<_7+VN"6Y:SZ$46]JS3A5=Y7
M&-G=D!VVZMKMV;HQNWD8Q[J%?V)ONQ)#6+1:4XJQ)0.V0SO"(*,'^M'2 J'1
M(UJ"]J9[6NK?AZ)2^D)!RI)!"6J;!):!9(4\#8ZP)Q*5L[CLLV53%>V%9.7<
M,-AV&%^GO9\T@G"?<>"H;B(!/_XM'KU!FA'=<JI5YM!5:ZY=79 46!^W<R[)
M=G,]N3SY].#^GG4M> B1NFD>EJJ-M"F?X!$1!S.\5]> =&;0"&Z%"K\-(ICX
MQX>)!#K_8^_A;KJ[NQOP\LT(+;)M@WMM5J*$8K0V&CM,Q2T,L&[)&BP:IC0D
M.>9-7LS'6*?(6&>J/.H7-F*((0=[9Q8+];+G*BTI=&+&(+9GE!+U.U"JOH(J
M-E-VUN?ZZZ&_-X(3!&>SEB\F:\89Z*(';S^4>22LMP*&*<O(.8 (.49P5P:Y
MSY*'N[L/!<O3Y#T$T !P'#PB2J5@$^+#4@*?%D]O\4P.(RN^_\X=6,,YFX.Y
M@"8#'?-K.+1SKB*$0XZRS- JD&RM2_1 \, 7@F03'EKKPH+#)_8+OLQW'!JT
M2@]?S[7^B; ]P#;+6% ['TN;V.!!USXR?5@$Q^'Z#T*+M,'"\:R7V^3DH]!.
M.,]W1?$YP:1K_($ A:G"6.)3.HG"XR^3YNHD!2,P(7E'A!G4OP)U)@V! L%5
M&>TH]#%3(?6P6H#L)R 8%\<8W%#PV%!9LF%DU[2%]-+L["+3%B&,A?0L<HEG
MWP:+G=T8KGI:S(3^)\)/#-H%'@'*.)_VVR#3!I0\TR2?+M'RW:((^DP;) ?E
M*B=T&O<>90_VGFSEC)C8>S+EO[:=\K<G:YJC?8N4$@2GO/GYU,J-KF [WX#D
M5Y:?]^*<A?9GY)!_P34YK>"TYB&5;/""5/7)Z^L02LR8,0?1J[38<F?\PM G
M$/I6Z38"XI)0/OF8LI-MQ+(5K)SG8"/HPC4;4F*U$7@GQT2CTO$,"Y1(@MT\
MVU$*$D9U*<I'";+(^_&3_?$TM\D6[P7"4>"7!KO$+T55?_!U0/H>XCO8/.;Y
M_33^8DTQ@=WANLK21Y&9S\;HLWW*A(^13$"ZX!6-KB*+5W>?WC18HH_>5YH$
M\KP_R&7)I"*Z]9SZD3$EN)!!/ %G!]]S2R-B%*PL D'0G[9^FU(%K5_FP\2X
M-+BAT^4 *67Q'LM&NWIX?7K'<6]LOZ'MUZXM=\#0*2SJZ[Y;C"*<? "&V*G,
M:I73!)?KF'V01.C3DS=-O5RDTAV9U'*-28 L=,,Y;NU!"36J+%F\4\./#/MW
MW-3O.=!2TWK#J?5<)7GNJ9AE;!G75FEG 1UJ3RN(KN2;6Y*#;'I9M.P3BB=$
MI5+\8 )I2D,_++>66#Q3'5%'0;P&_^M=8^'HC7$Q?"S#-LH^S_$KT60Z;$BC
MZYLNQJP#G;+8=Y0,$3:%,>=WK/-FWZ?UFX.J0+KK11Z^ DD)..1*UT@204)B
MTV6^BN/D(^=D<\KAE'?K3OEQ4URB"7FL.YB/^@@<BKEF13.L.<HFKC;/;S+7
MLC*@P9#(*3.G(W8@B*+IRC_:>9AR\-:42*^D HT1XY)X2-9P;@]/=SA\K@09
MM!F\/:FW!U>[PD<.B*'.9P-S'<]?V,-GLUMQMR[7)TB<6)5%7=7-BSTR5_;D
M [Y27#;%"NY\BI^02=$1)?\D+Q;2'^':!:_"-4^#G )&*O/8_=5@-8I@XLUV
MS/89MP!3?L9&&;ZEQDCVOGV\RUVBYL33%[XY2_PH@)ARE+!VJ)/;.I8>(<KQ
MVXS; /I6'-T[C'^SY6'+7]Z 9/=S?$))6M[S;WWD]C9$W2ZV$*>D4*;=50(X
M%>"<#ZFOI?FKAVT\+GT;#Q-TMCW*O6 FQ1#M<D*]TQ'_VD_Y5_WN";G'V]Y.
MQ2C4QS#'K.\J@$C6S0:&#7QU0_+--JK#]?\!HW>(%)FXYJ5Q]G&W>U^&#:]D
M1?-5+?[V'FZ=.^<S;)\S3!][DM.]APD\I;M8PPV>#LJ=70:I]Z)U+R4>C-\R
M^V ;/@:FXB)Y[)S;P'VLEJLA[@?>29>8N>T'W\EO[QD=C@+'#D_(=+!P"=R&
M0KK)P!\PH*:NBHGOBM9=@&MWSL]^E1-O+=:WG&$^*CPYDL\QH48"TW.DV_59
MCB&[E-N'D( !V2&Y&C)?*Y_NZ-QO-X+MF!/"2;KA^V\$  J #^L$@.]B%H01
M8DHKX%")U?!]O"\8(@Z)@@4?0:=+2Q>*SE%S!5YZQI1M-8<1Q?7%\^M: AKF
M$N->L/%8-!P5D)C$LFKSTB?*;/!:S3+'?N-[A'-S&%*!IG&XIUI&!!\3&X:$
ME%;<^3XU;FK-)/3&3J9A@\8Q!R(-(TN?]%"IR$E<VL5!7,PJ;1ITJ#%!44$%
M\&KV8PWKO3DLG&R<T%Y77)[*ND3+3)T$NJD=?;\?0ZQ=W[ 7(]%'$?4^KT'3
MY-(,(/ AM4_1'6CZ#4>_Y2.B2VY/PB^LF;\)$_]&6J*TO%YK+F4?B'1_.0RZ
M"A-28FBN/YD5Z%9LV/8X;5%EN&P3BKUJ;QA3E-,KA-7Z5\_R@;U)YGP"9IBX
MOD"/HH-7;_(.! #Q''C"<"9P=B1-GF:?>5.:HIU*X_D>T8MCL9>"]E:Z56&5
M.)$@>V\DI#2A@A[?L4'8%SQ4P!TNG#B"3*;8+.:J8D( 5%^4%)$LY)(JG+@F
MZ,87] B8"T&@92WF^U7]U/7[UC<JLVL+2_++DBJ1AU5]0=<!QP#MDY$@'7.N
MVA/!ZKH"Z)3&AT_O:T>_6)37O7Y4RXJFG9\J<LV-A:>/H\S!C(DVAU]12MRW
M-Y\-UMW7 W@87J@M$+"%GV'J8 7>?R.<4#C]<YUP>BT'^25HK27<YUBIT(1=
M<4AVZ@PJVQ:RJAV?\BH@W="G9VA=%A#L"P30&&AQ6R%R,SQ;*,L80J>"4_\B
MAA$VZV9+M)=F5*-49E>SI20;A8L$CL)Y,:,:?,Q%HMX.09#N5PX$Q^4-M-55
M,N(I H$(=MT$.5O 8"(V&S1-%-"R[1GEW2WU?*^XDY=I?"ZHQU3=6%"IJU1;
M/Q)7!8AEFS"GG*9#S]?UF.*)4NP-UDCR*VJ<2-H%.M"H\NUK7FE]0&>K;MR5
ME-Q?8YF[JN2>&TGE0=N^8KE?@B/]NPC&(X5.TX&X4H^%$08JA.'7KU\>CS8B
M!$5(EJV3(2/!1*V-]Q@4'+HHN%JOF^R?!9RGO\'^>PK.?DXD2X>'+V_!0<RE
M#?[!V!<K1/BQ321N#_S1$'*,G(1Z452QO"DY13'LFI(XAMVD^J]8P=0EHZK"
M&AD.F^(V?HWE:7N[#_Z>,B0QC'21?]>?FUX7NF%D<[,K<5>.Q^MWI>X>$I<G
MSI7T_B7NUF<,-H(%E+_<]R%&(<)QYAZ@8 =T",6DC$?!26:Q@&OK,B\=:FV2
M+;*),X5@H\S=KL)J5FP"HS>)[MHX<_K-;F]G\Z/Z8JX3JGU!#JO4_F7,NQ#
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M,G45$L;P5.7MIZ1[<5>N1/(P&K!VTS<TY@RNZQ,LNC0I9MY \,-QIB+'/3U
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M*X6"0)XL_;\D]1,7WR!B;<RPH1R8D"11C? #]6)+(SL+RTU /MH=-N 05#K
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M[:1M#?KEM3' M ^H^U#Z,"5A M?3',T9;%T>1-QMTU&A]POX2&=2 PQ?8YQ
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MKO*]J;TPL?2:JK9ARMMN#G\\'?^/$*Q33J\BPW3-(#U,24?I00KTVSZ-. X
M@T1>#IN #IE4%#FY#OP,Z7^I&+S;3AB*=>2@(P14=LW &<\$S=0_%%Z[SS;;
MPW5(^U.TTZ;9-0CT4]AY](_O:W26\%]Y-R%602$B*S/N2I<M%JBG:6F\K0-6
M@]!]F$A!K46)BZ()@,(<B;>"2H,[0;);HR3)"R48I&I[GR:2YRC)%5DNJBWX
M&1[_(ZV4Q!\A1@.J%6$E8Y]PCW?+.IS<2U-GX45A).)E(F]$&O]E'>DWKUJ8
MFXFB A:O#OTM1,8LL+Q]60F)(%XBK-8K UJIBWX+!(/?G'K3206%>P'GNBJI
MEH"<LOFX.%\*\6.3.V^^K4MR.Z4Z@6):33;K//@SV+)26N""<'>I/1'CR56%
MMX[KP$12);Y))B&%/B5VP=E'RFEQ'LTUV8DE^(IJI5?A#5.;!9S^O!32\1E9
M%\3CQT4&=7.%M2LM9PX79=$1$Q3^-2THHS!U'QB>4*ME- L>F-9>KYE6E+A<
MY)#'F$@V_.9\F!\^&S]?UQYO=/"/_9/D[>ODO]Z=_)2<G1R,#KE-+=+ZPO&6
M?\ M#HZ2T=%/R>CEV<';(U 6[P[.TN3M27)\\O;E_OZK@Z,WB5P"MSHX?75
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M^#Y'_5K,KM<)^,=/:' @<'\\.#L"V93\B(+M[>LTAM\D9XCB U/6C ;^H#&
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MSG+I6-)7M;&Y168*,N>_X.CKH5N09YYEDR&7"SX&3B<CR/-Z'8BBQEETMY1
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M<"UBX;NC4S:401PJ8)EV,Y[P!E?$2J&_'_CZ$OCJ)K4HU"6^<$&%?G407+K
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MV!R_J]L"0"@HJ<R:K"KL;*O]GDQ5_+8;.*%7&T?XTNOH.LT(G"8MBIHCT?Q
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M "PSDJ^"Y<_' S'JO!N7@4'S"+E&\9S%95:7/7E]).Y[J#W)YDN6;3&GQD3
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M>H>;2I$+'RE+L= !(V;4F.HB?VA0QFUT:)2 E%K&#7B8/HQ>['**HK<E#]9
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M;W>$-[L]3)%K!7E[B@854S3;</:S<D$)G:!;%>&[L$T7UT+(Y'[B\0)GOK:
M0>NL</5D+D)4CX,NI,+5[C92 ^]L(F7=(HQ'=A&!I15U*N$QKI+YM:RXT1)+
M38$.+:NX?/%0..ML9*R.RV][9M^I[$,WDC8NF.EE[UJ8&/PV[1ZA3:O3<OK
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MDW*5UJCFE<E56@$5A']&507 J?R]O2XR6)>[M;0*X!:AX@BS63<,WX3!5E4
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M#X(I*<L"P-I3*K,S9F4&!4)1%G +F$H9)5?Q M(2XQ25VQP-%?2Y6F=IK3Z
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MN?S4H3\$_D\4^,D$J+E%:Q:&:U\ ;K=:8R#^WFQ#)! DS@3CD@(,;A3"5-^
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M<T(FE6V;G299FFP8ZUL&\!+\[!C*,, 8G"+/MCIAF*IFPU#BL[;4X:T)5L2
M%-_DHHRG1<6R_Z+6<-EH6Y:0(]#FJ'PO13J3HPZ_H@ *$,C@S,NMV)FU*HZZ
MSBJG6FRTR3+!0G!%SAER#7N@-DGWV%*+]YO+IC7SMWA-EN.MLO45"I?>6C5
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M::ALJ2:>65E W+1A?Q6\'<9_W_!'"A+A>0$# %^?EXGXF"@_8LOA1XY]$G,
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M)]%[?<9 =\!HN^@J\2(HVMJOD_J3%Y[_ !TFBZWXZA9IN6)='"/,HKDION0
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M\W,*@,HM]"JI"77L]A;K>D9W!+WT[Q +%A%G$#NV<C>8YRA(4]T'5:YR<2?
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M%P=E<=/\$F,]@XM7H\LWYCK $_!<VU^PBD?HLCI^\6A9K[+C_P]02P,$%
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MFV@A=[UM. @4+;D+3DBQ^6Z^_P%02P,$%     @ "8&?63F^CVEH P  ;PT
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MPA+ EV HPGH'?<*_1BO<I["P3,,N7A)ELKN RRI;FQ%=D'7_Q<^?4$L#!!0
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MF=.2G2AK/)X-(=C.=R3? DO._ LC-"/R[0Y^;<= =\/U3Z)ZIBE_XK68I5D
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MGTF"AI\^'T?4C_K_&][Y%U!+ P04    "  )@9]9->E^HED2  #2?P  $P
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ML5^K'3W<[L>64'&!.#1HS,DT%#)$C06=[X8@YV:-&J85*3!J;GMF*X-/FG9
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M1/U&)>"LWUVZ-QX:PK^^>1,#>:)+![D9]5)^#1\B]/%[E4_^!U!+ 0(4 Q0
M   (  F!GUE3;.2\\G0  *]J @ -              "  0    !E>%\W-C$R
M-#DN:'1M4$L! A0#%     @ "8&?68F\_MHY1@  4IH!  T
M ( !'74  &5X7S<V,3(U,"YH=&U02P$"% ,4    "  )@9]99_D;H[0V   \
M @$ #0              @ &!NP  97A?-S8Q,C4Q+FAT;5!+ 0(4 Q0    (
M  F!GUE)7Z"BW 0  -0W   -              "  6#R  !E>%\W-C$R-3(N
M:'1M4$L! A0#%     @ "8&?63F^CVEH P  ;PT  !$              ( !
M9_<  '!R:W(M,C R-#$R,C0N>'-D4$L! A0#%     @ "8&?6:&'IC^3!
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G:W(R,#(T,3(S,%\X:RYH=&U02P4&      D "0 U @  8AP!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>prkr20241230_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prkr-20241224.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914139</identifier>
        </entity>
        <period>
            <startDate>2024-12-24</startDate>
            <endDate>2024-12-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K" id="ixv-287">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K" id="ixv-288">0000914139</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K" id="ixv-17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K" id="ixv-27">2024-12-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K" id="ixv-31">PARKERVISION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K" id="ixv-43">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K" id="ixv-47">000-22904</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K" id="ixv-51">59-2971472</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K" id="ixv-69">4446-1A Hendricks Avenue Suite 354</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K" id="ixv-74">Jacksonville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K" id="ixv-77">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K" id="ixv-82">32207</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K" id="ixv-92">904</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K" id="ixv-95">732-6100</dei:LocalPhoneNumber>
    <dei:SolicitingMaterial contextRef="d20248K" id="ixv-298">false</dei:SolicitingMaterial>
    <dei:WrittenCommunications contextRef="d20248K" id="ixv-299">false</dei:WrittenCommunications>
    <dei:PreCommencementTenderOffer contextRef="d20248K" id="ixv-300">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K" id="ixv-301">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K" id="ixv-302">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
